Home  |  Contact

Cellosaurus MZ-MEL-2 (CVCL_1435)

[Text version]

Cell line name MZ-MEL-2
Synonyms Mz-Mel-2; MZ Mel 2; MZ-2 Mel; MZ2-MEL; MZ2-Mel; MZ2-mel; MZ2MEL
Accession CVCL_1435
Resource Identification Initiative To cite this cell line use: MZ-MEL-2 (RRID:CVCL_1435)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: COSMIC cell lines project.
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: Deep RNAseq analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Sequence variations NRAS p.Gln61Lys (c.181C>A) (ClinVar=VCV000073058) (PubMed=25728708).
Genome ancestry Source: PubMed=30894373

Origin% genome
African0
Native American0.15
East Asian, North0.41
East Asian, South0.66
South Asian0.41
European, North64.57
European, South33.8
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Sex unspecified
Age at sampling Age unspecified
Category Cancer cell line
STR profile Source(s): Cosmic-CLP

Markers:
AmelogeninX
CSF1PO10
D5S8189,11
D7S82010,12
D13S31712
D16S53912,13
TH018,9.3
TPOX8,12
vWA16,18

Run an STR similarity search on this cell line
Publications

PubMed=9637538
Gueguen M., Patard J.-J., Gaugler B., Brasseur F., Renauld J.-C., Van Cangh P.J., Boon T., van den Eynde B.J.
An antigen recognized by autologous CTLs on a human bladder carcinoma.
J. Immunol. 160:6188-6194(1998)

PubMed=20164919; DOI=10.1038/nature08768
Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)

PubMed=25502142; DOI=10.1038/ncomms6712
Muller J., Krijgsman O., Tsoi J., Robert L., Hugo W., Song C., Kong X., Possik P.A., Cornelissen-Steijger P.D.M., Geukes Foppen M.H., Kemper K., Goding C.R., McDermott U., Blank C., Haanen J., Graeber T.G., Ribas A., Lo R.S., Peeper D.S.
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Nat. Commun. 5:5712-5712(2014)

PubMed=25728708; DOI=10.1111/pcmr.12364
Vogel C.J., Smit M.A., Maddalo G., Possik P.A., Sparidans R.W., van der Burg S.H., Verdegaal E.M., Heck A.J.R., Samatar A.A., Beijnen J.H., Altelaar A.F., Peeper D.S.
Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK.
Pigment Cell Melanoma Res. 28:307-317(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

Cross-references
Cell line databases/resources CCLE; MZ2MEL_SKIN
Cell_Model_Passport; SIDM00179
Cosmic-CLP; 971777
DepMap; ACH-002165
LINCS_LDP; LCL-1278
Chemistry resources ChEMBL-Cells; CHEMBL3308272
ChEMBL-Targets; CHEMBL2366226
GDSC; 971777
PharmacoDB; MZ2MEL_976_2019
Gene expression databases ArrayExpress; E-MTAB-783
ArrayExpress; E-MTAB-3610
GEO; GSM1507939
GEO; GSM1670140
Other Wikidata; Q54907223
Polymorphism and mutation databases Cosmic; 971777
Entry history
Entry creation04-Apr-2012
Last entry update29-Oct-2020
Version number24